Form 4 for WST West Pharmaceutical Services
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0001562180-23-006299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-11 | 2023-08-09 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $137.87 | +1,680 | 3,510 | +92% | +$231.6K |
| D | 2023-08-11 | 2023-08-09 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $396.54 | -1,680 | 1,830 | -48% | -$666.2K |
| DM | 2023-08-11 | 2023-08-09 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -1,680 | 708 | -70% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | M | A | 840 | $102.51 | 2,669.50 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-09 | S | D | 1,680 | $396.54 | 1,829.50 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-09 | M | A | 840 | $173.22 | 3,509.50 | D | — | — | |
| 4 | Derivative | Stock Options (Right to buy) | 2023-08-09 | M | D | 840 | $0.00 | 1,072 | D | $173.22 · 2021-02-18 to 2030-02-18 | 840 Common Stock | |
| 5 | Derivative | Stock Options (Right to buy) | 2023-08-09 | M | D | 840 | $0.00 | 708 | D | $102.51 · 2020-02-19 to 2029-02-19 | 840 Common Stock |